4//SEC Filing
Struthers Richard Scott 4
Accession 0001658247-25-000011
CIK 0001658247other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:42 PM ET
Size
8.4 KB
Accession
0001658247-25-000011
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-09-26$45.00/sh−4,000$180,000→ 106,000 total(indirect: By Trust)
Holdings
- 661,205(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 320,017
Common Stock
- 100,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $45.00 per share.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001746298
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:42 PM ET
- Size
- 8.4 KB